RushNet, Inc. acquired all rights and assets of StopDrops, Inc.
December 11, 2019
Share
RushNet, Inc. (OTCPK:RSHN) acquired all rights and assets of StopDrops, Inc. on December 11, 2019. StopDrops will operate as separate entity.
RushNet, Inc. (OTCPK:RSHN) completed the acquisition of all rights and assets of StopDrops, Inc. on December 11, 2019.
RushNet, Inc. operates under the name HeliosDX. HeliosDX is a national clinical reference laboratory offering high-complexity urine drug testing (UDT), behavioral drug testing, allergy droplet cards, oral fluids, and infectious disease (PCR). The Company provides management services and insurance billing services principally to clinical reference laboratories. It provides PGX testing through Leo Partners. It provides oral fluid toxicology testing for a range of drugs. The Quantisal Collection Procedure makes taking the sample quick and easy. HeliosDX also offers a preliminary 10-panel plus adulteration detection screen, as well as confirmation testing via its comprehensive toxicology panel. Its subsidiaries include Chattahoochee Physicians Laboratory Services, LLC; doing business as HeliosDx and Grandeza Healthcare Consultants, LLC.
RUSHNET, INC. 